Abstract
Facial rejuvenation has become an important subject of psychosocial wellbeing in this era of fashion and beauty. Injectables offer an excellent non-surgical method of facial rejuvenation. Among which, botulinum toxin and soft tissue fillers are one of the most common and favorite tools for non-surgical rejuvenation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Readings
Kamal S, Goel R, Bodh SA, Kumar S. Fillers in ophthalmic practice. Del J Ophthalmol. 2012;23(1):61–6.
Fagien S. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping. Plast Reconstr Surg. 2003;112(5 Suppl):6S–18S.
Schantz EJ, Johnson EA. Botulinum toxin: the story of its development for the treatment of human disease. Perspect Biol Med. 1997;40(3):317–327.
Fagien S, Brandt FS. Primary and adjunctive use of botulinumtoxin type A (BONTA) in facial aesthetic surgery: beyond the glabella. Clin Plast Surg. 2001;28(1):127–48.
Rohrich RJ, Janis JE, Fagien S, Stuzin JM. The cosmetic use of botulinum toxin. Plast Reconstr Surg. 2003;112(5 Suppl):177S–88.
Carruthers JD, Glogau RG, Blitzer A. Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies—consensus recommendations. Plast Reconstr Surg. 2008;121(5 Suppl):5S–30.
Walgama EAR, Gilmore J. Botulinum toxin for the facial cosmetic surgeon. Am J Cosmet Surg. 2010;27(2):49–61.
Hexsel DM, De Almeida AT, Rutowitsch M, et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Dermatol Surg. 2003;29(5):523–9.
Vedamurthy M. Standard guidelines for the use of dermal fillers. Indian J Dermatolo Venereol Leprol. 2008;74, Suppl S1:23–7.
Kontis TC, Rivkin A. The history of injectable facial fillers. Facial Plast Surg. 2009;25(2):67–72.
Murray CA, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice. DermatolClin. 2005;23(2):343–63.
Smith KC. Reversible vs. non-reversible fillers in facial aesthetics: concerns and considerations. Dermatol Online J. 2008;14(8):3.
Brennan C. Avoiding the “Danger Zones” when injecting dermal fillers and volume enhancers. Am Soc Plast Surg Nurses. 2014;34 (3):108.
Gilbert E, Hui A, Meehan S, Waldorf H. The basic science of dermal fillers: past and present Part II: adverse events. J Drugs Dermatol. 2012;11(9):1069–79.
Dormston W, Hilton S. A prospective, open label, multicenter, observational, postmarket study of the use of 15 mg/ml hyaluronic acid dermal fillers in lips. J Cosmet Dermtol. 2014;13(2):125–34.
Jordan DR. Soft-tissue fillers for wrinkles, folds and volume augmentation. Can J Ophthalmol. 2003;38(4):285–8.
Beasley KL, Weiss MA, Weiss RA. Hyaluronic acid fillers: a comprehensive review. Facial Plast Surg. 2009;25(2):86–94.
Bray D, Hopkins C, Roberts DN. A review of dermal fillers in facial plastic surgery. Curr Opin Otolaryngol Head Neck Surg. 2010;18(4):295–302.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bhattacharjee, K., Goel, S., Ghosh, S., El Toukhy, E.A. (2020). The Cosmetic Use of Injectables in Oculoplasty. In: El Toukhy, E. (eds) Oculoplastic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-36934-7_18
Download citation
DOI: https://doi.org/10.1007/978-3-030-36934-7_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-36933-0
Online ISBN: 978-3-030-36934-7
eBook Packages: MedicineMedicine (R0)